# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-26-028571
Filing Date
2026-04-30
Accepted
2026-04-30 06:59:07
Documents
18
Period of Report
2026-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rmti-20260428.htm iXBRL | DEF 14A | 611837
3 |  | rmti-20260428_g1.jpg | GRAPHIC | 1691
4 |  | rmti-20260428_g2.jpg | GRAPHIC | 40638
5 |  | rmti-20260428_g3.jpg | GRAPHIC | 296789
6 |  | rmti-20260428_g4.jpg | GRAPHIC | 298997
7 |  | rmti-20260428_g5.jpg | GRAPHIC | 508957
8 |  | rmti-20260428_g6.jpg | GRAPHIC | 258770
| Complete submission text file | 0001628280-26-028571.txt |  | 4322498

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rmti-20260428.xsd | EX-101.SCH | 922
21 | EXTRACTED XBRL INSTANCE DOCUMENT | rmti-20260428_htm.xml | XML | 64230

Mailing Address 30142 WIXOM ROAD WIXOM MI 48393
Business Address 30142 WIXOM ROAD WIXOM MI 48393 8004493353
ROCKWELL MEDICAL, INC. (Filer) CIK: 0001041024 (see all company filings)

EIN.: 383317208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23661 | Film No.: 26919963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)